{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T03:02:17Z","timestamp":1795230137188,"version":"4.10.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["1RF1AG058273-01"],"award-info":[{"award-number":["1RF1AG058273-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Aging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Soluble epoxide hydrolase (sEH) is upregulated in microvascular endothelium of human brain with vascular cognitive impairment (VCI). Transgenic endothelial expression of human sEH in mice (Tie2hsEH) induces endothelial dysfunction (ED), a pathogenetic mechanism of VCI. We sought to determine if endothelial upregulation of sEH is sufficient to cause cognitive impairment, and if cognitive impairment due to chronic hypoperfusion induced by unilateral common carotid artery occlusion (CCAO) is exacerbated in Tie2hsEH mice. Behavioral performance was assessed by the open field, rotarod, novel object, Morris water maze and fear conditioning tests. Cerebral blood flow and brain morphology were evaluated by MRI, and inflammatory changes investigated using immunohistochemistry and flow cytometry. We demonstrate that transgenic endothelial expression of sEH is sufficient to induce cognitive impairment, associated with leukocyte infiltration, brain atrophy and accelerated, age-dependent ventriculomegaly, identifying ED and sEH upregulation as potential underlying mechanisms and therapeutic targets for VCI.<\/jats:p>","DOI":"10.1038\/s41514-022-00090-1","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T11:10:02Z","timestamp":1657019402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Age-dependent cognitive impairment, hydrocephalus and leukocyte infiltration in transgenic mice with endothelial expression of human EPHX2"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9654-3509","authenticated-orcid":false,"given":"Catherine M.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenri H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0288-1721","authenticated-orcid":false,"given":"Thierno M.","family":"Bah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie E.","family":"Roese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philberta","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney J.","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Marzulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah N.","family":"Alkayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5191-7244","authenticated-orcid":false,"given":"Michael A.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9861-9893","authenticated-orcid":false,"given":"Jacob","family":"Raber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin M.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3489-4730","authenticated-orcid":false,"given":"Nabil J.","family":"Alkayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"90_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10571-015-0319-y","volume":"36","author":"C Iadecola","year":"2016","unstructured":"Iadecola, C. Vascular and metabolic factors in Alzheimer\u2019s disease and related dementias: introduction. Cell. Mol. Neurobiol. 36, 151\u2013154 (2016).","journal-title":"Cell. Mol. Neurobiol."},{"key":"90_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","volume":"277","author":"DA Snowdon","year":"1997","unstructured":"Snowdon, D. A. et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813\u2013817 (1997).","journal-title":"JAMA"},{"key":"90_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fnagi.2018.00376","volume":"10","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. Dysfunction of cerebrovascular endothelial cells: prelude to vascular dementia. Front. Aging Neurosci. 10, 376 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"90_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2017.05.004","volume":"179","author":"CM Davis","year":"2017","unstructured":"Davis, C. M., Liu, X. & Alkayed, N. J. Cytochrome P450 eicosanoids in cerebrovascular function and disease. Pharmacol. Ther. 179, 31\u201346 (2017).","journal-title":"Pharmacol. Ther."},{"key":"90_CR5","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1177\/0271678X15616400","volume":"36","author":"KL Zuloaga","year":"2016","unstructured":"Zuloaga, K. L. et al. High fat diet-induced diabetes in mice exacerbates cognitive deficit due to chronic hypoperfusion. J. Cereb. Blood Flow Metab. 36, 1257\u20131270 (2016).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"90_CR6","doi-asserted-by":"publisher","first-page":"e97529","DOI":"10.1371\/journal.pone.0097529","volume":"9","author":"KL Zuloaga","year":"2014","unstructured":"Zuloaga, K. L. et al. Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke. PLoS ONE 9, e97529 (2014).","journal-title":"PLoS ONE"},{"key":"90_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.prostaglandins.2014.09.003","volume":"113-115","author":"JW Nelson","year":"2014","unstructured":"Nelson, J. W. et al. Role of soluble epoxide hydrolase in age-related vascular cognitive decline. Prostaglandins Other Lipid Mediat. 113-115, 30\u201337 (2014).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"90_CR8","doi-asserted-by":"publisher","first-page":"e61244","DOI":"10.1371\/journal.pone.0061244","volume":"8","author":"W Zhang","year":"2013","unstructured":"Zhang, W. et al. Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injury. PLoS ONE 8, e61244 (2013).","journal-title":"PLoS ONE"},{"key":"90_CR9","doi-asserted-by":"publisher","unstructured":"Zhang, W. et al. Role of endothelium-pericyte signaling in capillary blood flow response to neuronal activity. J. Cereb. Blood Flow Metab. https:\/\/doi.org\/10.1177\/0271678x211007957 (2021).","DOI":"10.1177\/0271678x211007957"},{"key":"90_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12975-015-0412-z","volume":"6","author":"KL Zuloaga","year":"2015","unstructured":"Zuloaga, K. L. et al. Neurobehavioral and imaging correlates of hippocampal atrophy in a mouse model of vascular cognitive impairment. Transl. Stroke Res. 6, 390\u2013398 (2015).","journal-title":"Transl. Stroke Res."},{"key":"90_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.31887\/DCNS.2016.18.4\/cepperson","volume":"18","author":"JL Podcasy","year":"2016","unstructured":"Podcasy, J. L. & Epperson, C. N. Considering sex and gender in Alzheimer disease and other dementias. Dialogues Clin. Neurosci. 18, 437\u2013446 (2016).","journal-title":"Dialogues Clin. Neurosci."},{"key":"90_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.4062\/biomolther.2018.159","volume":"26","author":"MY Kim","year":"2018","unstructured":"Kim, M. Y., Kim, K., Hong, C. H., Lee, S. Y. & Jung, Y. S. Sex differences in cardiovascular risk factors for dementia. Biomol. Ther. 26, 521\u2013532 (2018).","journal-title":"Biomol. Ther."},{"key":"90_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archneur.60.7.989","volume":"60","author":"RI Scahill","year":"2003","unstructured":"Scahill, R. I. et al. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch. Neurol. 60, 989\u2013994 (2003).","journal-title":"Arch. Neurol."},{"key":"90_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1749-6632.2000.tb06393.x","volume":"903","author":"JS Meyer","year":"2000","unstructured":"Meyer, J. S., Rauch, G. M., Rauch, R. A., Haque, A. & Crawford, K. Cardiovascular and other risk factors for Alzheimer\u2019s disease and vascular dementia. Ann. N. Y. Acad. Sci. USA 903, 411\u2013423 (2000).","journal-title":"Ann. N. Y. Acad. Sci. USA"},{"key":"90_CR15","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","volume":"80","author":"C Iadecola","year":"2013","unstructured":"Iadecola, C. The pathobiology of vascular dementia. Neuron 80, 844\u2013866 (2013).","journal-title":"Neuron"},{"key":"90_CR16","first-page":"40","volume":"68","author":"HE L\u00f3pez-Vald\u00e9s","year":"2016","unstructured":"L\u00f3pez-Vald\u00e9s, H. E. & Mart\u00ednez-Coria, H. The role of neuroinflammation in age-related dementias. Rev. Investig. Clin. 68, 40\u201348 (2016).","journal-title":"Rev. Investig. Clin."},{"key":"90_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature20411","volume":"539","author":"T Wyss-Coray","year":"2016","unstructured":"Wyss-Coray, T. Ageing, neurodegeneration and brain rejuvenation. Nature 539, 180\u2013186 (2016).","journal-title":"Nature"},{"key":"90_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff, R. M. How neuroinflammation contributes to neurodegeneration. Science 353, 777\u2013783 (2016).","journal-title":"Science"},{"key":"90_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat. Rev. Neurosci. 12, 723\u2013738 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"90_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bpa.12152","volume":"24","author":"EA Winkler","year":"2014","unstructured":"Winkler, E. A., Sagare, A. P. & Zlokovic, B. V. The pericyte: a forgotten cell type with important implications for Alzheimer\u2019s disease? Brain Pathol. 24, 371\u2013386 (2014).","journal-title":"Brain Pathol."},{"key":"90_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-020-03160-0","volume":"590","author":"PS Minhas","year":"2021","unstructured":"Minhas, P. S. et al. Restoring metabolism of myeloid cells reverses cognitive decline in ageing. Nature 590, 122\u2013128 (2021).","journal-title":"Nature"},{"key":"90_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.4049\/jimmunol.2000037","volume":"205","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Depletion of NK cells improves cognitive function in the Alzheimer disease mouse model. J. Immunol. 205, 502\u2013510 (2020).","journal-title":"J. Immunol."},{"key":"90_CR23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/00004647-200109000-00009","volume":"21","author":"M Bernardes-Silva","year":"2001","unstructured":"Bernardes-Silva, M., Anthony, D. C., Issekutz, A. C. & Perry, V. H. Recruitment of neutrophils across the blood-brain barrier: the role of E- and P-selectins. J. Cereb. Blood Flow Metab. 21, 1115\u20131124 (2001).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"90_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-020712-164023","volume":"9","author":"TN Mayadas","year":"2014","unstructured":"Mayadas, T. N., Cullere, X. & Lowell, C. A. The multifaceted functions of neutrophils. Annu. Rev. Pathol. 9, 181\u2013218 (2014).","journal-title":"Annu. Rev. Pathol."},{"key":"90_CR25","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","volume":"21","author":"E Zenaro","year":"2015","unstructured":"Zenaro, E. et al. Neutrophils promote Alzheimer\u2019s disease-like pathology and cognitive decline via LFA-1 integrin. Nat. Med. 21, 880\u2013886 (2015).","journal-title":"Nat. Med."},{"key":"90_CR26","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jalz.2018.06.2857","volume":"14","author":"GL Bowman","year":"2018","unstructured":"Bowman, G. L. et al. Blood\u2013brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimers Dement. 14, 1640\u20131650 (2018).","journal-title":"Alzheimers Dement."},{"key":"90_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/ana.25159","volume":"83","author":"Y Dong","year":"2018","unstructured":"Dong, Y. et al. Neutrophil hyperactivation correlates with Alzheimer\u2019s disease progression. Ann. Neurol. 83, 387\u2013405 (2018).","journal-title":"Ann. Neurol."},{"key":"90_CR28","doi-asserted-by":"publisher","first-page":"577398","DOI":"10.1016\/j.jneuroim.2020.577398","volume":"349","author":"A Sayed","year":"2020","unstructured":"Sayed, A. et al. The neutrophil-to-lymphocyte ratio in Alzheimer\u2019s disease: Current understanding and potential applications. J Neuroimmunol 349, 577398 (2020).","journal-title":"J Neuroimmunol"},{"key":"90_CR29","doi-asserted-by":"publisher","first-page":"103236","DOI":"10.18632\/oncotarget.21139","volume":"8","author":"TH Hung","year":"2017","unstructured":"Hung, T. H. et al. Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury. Oncotarget 8, 103236\u2013103260 (2017).","journal-title":"Oncotarget"},{"key":"90_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1005-4","volume":"14","author":"CH Wu","year":"2017","unstructured":"Wu, C. H. et al. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage. J Neuroinflammation 14, 230 (2017).","journal-title":"J Neuroinflammation"},{"key":"90_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08227-z","volume":"7","author":"Y Chen","year":"2017","unstructured":"Chen, Y. et al. Soluble epoxide hydrolase inhibition promotes white matter integrity and long-term functional recovery after chronic hypoperfusion in mice. Sci. Rep. 7, 7758 (2017).","journal-title":"Sci. Rep."},{"key":"90_CR32","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/CIRCRESAHA.111.259325","volume":"110","author":"D Zhang","year":"2012","unstructured":"Zhang, D. et al. Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Circ. Res. 110, 808\u2013817 (2012).","journal-title":"Circ. Res."},{"key":"90_CR33","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1161\/STROKEAHA.114.008560","volume":"46","author":"DA Siler","year":"2015","unstructured":"Siler, D. A. et al. Soluble epoxide hydrolase in hydrocephalus, cerebral edema, and vascular inflammation after subarachnoid hemorrhage. Stroke 46, 1916\u20131922 (2015).","journal-title":"Stroke"},{"key":"90_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23508-y","volume":"12","author":"K Shaw","year":"2021","unstructured":"Shaw, K. et al. Neurovascular coupling and oxygenation are decreased in hippocampus compared to neocortex because of microvascular differences. Nat. Commun. 12, 3190 (2021).","journal-title":"Nat. Commun."},{"key":"90_CR35","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/jcbfm.2015.162","volume":"35","author":"S Tarantini","year":"2015","unstructured":"Tarantini, S. et al. Pharmacologically-induced neurovascular uncoupling is associated with cognitive impairment in mice. J. Cereb. Blood Flow Metab. 35, 1871\u20131881 (2015).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"90_CR36","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1194\/jlr.M006007","volume":"51","author":"C Morisseau","year":"2010","unstructured":"Morisseau, C. et al. Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids. J. Lipid Res. 51, 3481\u20133490 (2010).","journal-title":"J. Lipid Res."},{"key":"90_CR37","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1124\/jpet.303.2.768","volume":"303","author":"D Ye","year":"2002","unstructured":"Ye, D. et al. Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. J. Pharmacol. Exp. Ther. 303, 768\u2013776 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"90_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.clnu.2020.05.034","volume":"40","author":"M Yuan","year":"2021","unstructured":"Yuan, M. et al. Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: a randomized, controlled trial. Clin. Nutr. 40, 445\u2013459 (2021).","journal-title":"Clin. Nutr."},{"key":"90_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/FJC.0000000000000094","volume":"64","author":"A Ulu","year":"2014","unstructured":"Ulu, A. et al. An omega-3 epoxide of docosahexaenoic acid lowers blood pressure in angiotensin-II-dependent hypertension. J. Cardiovasc. Pharmacol. 64, 87\u201399 (2014).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"90_CR40","doi-asserted-by":"publisher","unstructured":"Yang, Y. et al. Differential effects of 17,18-EEQ and 19,20-EDP combined with soluble epoxide hydrolase inhibitor t-TUCB on diet-induced obesity in mice. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22158267 (2021).","DOI":"10.3390\/ijms22158267"},{"key":"90_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pharmthera.2017.10.016","volume":"183","author":"WH Schunck","year":"2018","unstructured":"Schunck, W. H., Konkel, A., Fischer, R. & Weylandt, K. H. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases. Pharmacol. Ther. 183, 177\u2013204 (2018).","journal-title":"Pharmacol. Ther."},{"key":"90_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.prostaglandins.2014.09.001","volume":"113-115","author":"K Wagner","year":"2014","unstructured":"Wagner, K., Vito, S., Inceoglu, B. & Hammock, B. D. The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling. Prostaglandins Other Lipid Mediat. 113-115, 2\u201312 (2014).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"90_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","volume":"180","author":"KM Wagner","year":"2017","unstructured":"Wagner, K. M., McReynolds, C. B., Schmidt, W. K. & Hammock, B. D. Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. Pharmacol. Ther. 180, 62\u201376 (2017).","journal-title":"Pharmacol. Ther."},{"key":"90_CR44","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1073\/pnas.1422590112","volume":"112","author":"C L\u00f3pez-Vicario","year":"2015","unstructured":"L\u00f3pez-Vicario, C. et al. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides. Proc. Natl Acad. Sci. USA 112, 536\u2013541 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"90_CR45","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1073\/pnas.0437724100","volume":"100","author":"JW Newman","year":"2003","unstructured":"Newman, J. W., Morisseau, C., Harris, T. R. & Hammock, B. D. The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc. Natl Acad. Sci. USA 100, 1558\u20131563 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"90_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fnmol.2019.00325","volume":"12","author":"MF Domingues","year":"2019","unstructured":"Domingues, M. F., Callai-Silva, N., Piovesan, A. R. & Carlini, C. R. Soluble epoxide hydrolase and brain cholesterol metabolism. Front. Mol. Neurosci. 12, 325 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"90_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/cvr\/cvr267","volume":"93","author":"HH Hou","year":"2012","unstructured":"Hou, H. H. et al. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase. Cardiovasc. Res. 93, 120\u2013129 (2012).","journal-title":"Cardiovasc. Res."},{"key":"90_CR48","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.2741\/2889","volume":"13","author":"IP Koerner","year":"2008","unstructured":"Koerner, I. P. et al. Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia. Front. Biosci. 13, 2833\u20132841 (2008).","journal-title":"Front. Biosci."},{"key":"90_CR49","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/jcbfm.2009.65","volume":"29","author":"W Zhang","year":"2009","unstructured":"Zhang, W. et al. Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia. J. Cereb. Blood Flow Metab. 29, 1475\u20131481 (2009).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"90_CR50","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1161\/ATVBAHA.112.251520","volume":"32","author":"NC Gupta","year":"2012","unstructured":"Gupta, N. C., Davis, C. M., Nelson, J. W., Young, J. M. & Alkayed, N. J. Soluble epoxide hydrolase: sex differences and role in endothelial cell survival. Arterioscler. Thromb. Vasc. Biol. 32, 1936\u20131942 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"90_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12975-012-0227-0","volume":"4","author":"CM Davis","year":"2013","unstructured":"Davis, C. M., Fairbanks, S. L. & Alkayed, N. J. Mechanism of the sex difference in endothelial dysfunction after stroke. Transl. Stroke Res. 4, 381\u2013389 (2013).","journal-title":"Transl. Stroke Res."},{"key":"90_CR52","doi-asserted-by":"publisher","unstructured":"Anagnostaras, S. G. et al. Automated assessment of pavlovian conditioned freezing and shock reactivity in mice using the video freeze system. Front. Behav. Neurosci. 4, https:\/\/doi.org\/10.3389\/fnbeh.2010.00158 (2010).","DOI":"10.3389\/fnbeh.2010.00158"},{"key":"90_CR53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/mrm.1910340303","volume":"34","author":"SG Kim","year":"1995","unstructured":"Kim, S. G. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn. Reson. Med. 34, 293\u2013301 (1995).","journal-title":"Magn. Reson. Med."}],"container-title":["npj Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41514-022-00090-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-022-00090-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41514-022-00090-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:19:21Z","timestamp":1669299561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41514-022-00090-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["90"],"URL":"https:\/\/doi.org\/10.1038\/s41514-022-00090-1","relation":{},"ISSN":["2731-6068"],"issn-type":[{"value":"2731-6068","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"assertion":[{"value":"10 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Financial competing interests are as follows: N.J.A. is co-inventor of technologies related to sEH and EETs signaling that have been licensed by OHSU and JHU to Precision Molecular and Vasocardea. This potential conflict of interest has been reviewed and managed by OHSU. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}